PenderFund Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

PenderFund Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,800	Closed	-$148K	–	139
2023 Q4	$148K	Buy	+1,800	New	+$44.7K	0.05%	80

PenderFund Capital Management's RYZB Position: Q1 2024 in Review

PenderFund Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,800 shares — an estimated $148K sold.

PenderFund Capital Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $148K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

PenderFund Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
PenderFund Capital Management sold 1,800 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $148K.
PenderFund Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
PenderFund Capital Management's RayzeBio, Inc. Common Stock position peaked at $148K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on PenderFund Capital Management's 13F filing for Q1 2024, filed 15 May 2024.